Firefighters' toxic burden: drug may flush out 'Forever Chemicals'
NCT ID NCT07226440
First seen Nov 11, 2025 · Last updated May 21, 2026 · Updated 26 times
Summary
This study tests whether a drug called colesevelam, which binds to bile acids, can help lower levels of PFAS (often called 'forever chemicals') in the blood of 50 male firefighters who have high exposure. Participants will take the drug or a placebo for several weeks, then switch. The main goal is to see if the drug is acceptable and easy to take, while also checking if it reduces PFAS levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOXICANT EXPOSURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UCSF Osher Center for Integrative Health
RECRUITINGSan Francisco, California, 94115, United States
Contact
Contact Email: •••••@•••••
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.